SCHEMBL18833102

SCHEMBL18833102

COC(=O)CN=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5741106 0.77 TSHR (0.61)
SCHEMBL29599022 0.77 TSHR (0.61)
SCHEMBL25978623 0.74
SCHEMBL2970124 0.74
SCHEMBL9921787 0.74
SCHEMBL255150 0.72
SCHEMBL23977542 0.72
SCHEMBL17643549 0.72 CYP2D6 (0.37)
SCHEMBL19231596 0.72
Dimethyl Succinate SCHEMBL28054469 0.72 TSHR (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11680073-B2 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses ADT PHARMACEUTICALS, LLC (US) 2023-06-20 US disclosed
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 WO disclosed
EP-3615522-B1 C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2021-08-04 EP disclosed
EP-2740723-B1 SULPHAMIDE DERIVATIVE HAVING AN ADAMANTYL GROUP AND A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KOREA RES INST CHEMICAL TECH (KR) 2017-05-10 EP disclosed